HEPCDAC 60MG

What is HEPCDAC 60MG?

HEPCDAC 60MG is an antiviral medicine used in the treatment of Chronic Hepatitis C infection. It contains Daclatasvir 60 mg, which belongs to a class of drugs called direct-acting antivirals (DAAs). It helps reduce viral load in the body and prevents the virus from multiplying, supporting recovery of liver function.

---

What is the use of HEPCDAC 60MG?

• Used for the treatment of chronic Hepatitis C (HCV) infection

• Helps in reducing liver inflammation caused by the virus

• Prevents complications such as cirrhosis and liver failure

• Often used in combination with other antivirals like Sofosbuvir for effective viral clearance

---

Benefits of HEPCDAC 60MG

• Highly effective in eradicating Hepatitis C virus from the body

• Shorter treatment duration compared to older therapies

• Improved long-term liver health

• Better tolerance and fewer side effects compared to interferon-based treatments

---

Side Effects of HEPCDAC 60MG

Most side effects are mild and manageable. They may include:

• Headache

• Fatigue or tiredness

• Nausea

• Mild fever

• Dizziness
  In rare cases:

• Severe allergic reactions

• Anemia (when combined with certain drugs)

Consult a doctor if any side effects persist or worsen.

---

Dosage & Administration

HEPCDAC 60MG is usually taken once daily as directed by a healthcare professional. It is most commonly given in combination with Sofosbuvir or other antivirals, depending on the patient’s genotype and liver condition. The typical treatment duration is 12 to 24 weeks.

Q1. What is HEPCDAC 60MG used for?
HEPCDAC 60MG is used for the treatment of chronic Hepatitis C virus (HCV) infection.

Q2. What is the active ingredient in HEPCDAC 60MG?
It contains Daclatasvir 60 mg, a direct-acting antiviral (DAA).

Q3. Can HEPCDAC 60MG be taken alone?
No. It is usually taken in combination with Sofosbuvir or other antivirals for best results.

Q4. How does HEPCDAC 60MG work?
It blocks the replication of the Hepatitis C virus inside the body, helping the immune system clear the infection.

Q5. What is the usual duration of treatment?
Treatment typically lasts 12 to 24 weeks, depending on liver condition and viral genotype.

Q6. When will I start seeing results?
Viral load reduction is often seen within 4 weeks, but treatment must be continued as prescribed to prevent relapse.

Q7. Can HEPCDAC 60MG cure Hepatitis C completely?
Yes, when taken with appropriate combination therapy, it shows very high cure rates (SVR – Sustained Virologic Response).

Q8. What are the common side effects?
Common side effects include headache, fatigue, nausea, dizziness, and mild fever.

Q9. Can I drink alcohol during treatment?
No. Alcohol damages the liver and reduces the effectiveness of treatment.

Q10. Is HEPCDAC 60MG safe in pregnancy?
It should be used only under strict medical supervision in pregnancy. Discuss risks with your doctor.

Q11. Can I stop taking HEPCDAC 60MG if I feel better?
No. Stopping early can lead to treatment failure or virus recurrence.

Q12. What if I miss a dose?
Take it as soon as you remember, but skip it if it’s almost time for the next dose. Don’t double dose.

Q13. Can this medicine be used in patients with cirrhosis?
Yes, but dosage and combination therapy may be adjusted based on liver disease severity.

Q14. Is monitoring required during treatment?
Yes. Liver function tests and viral load tests are usually done during therapy.

Q15. How should HEPCDAC 60MG be stored?
Store below 30°C, in a dry place away from light and moisture.